Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle
Tóm tắt
The aim of this study was to determine the nature of incidental ovarian 18F-fluoro-2-deoxyglucose (FDG) accumulation on positron emission tomography (PET) and the correlation with the menstrual cycle and menopause. We identified 19 incidental FDG accumulations in the ovary (FAOs). FDG PET images were compared with other anatomical imaging methods [magnetic resonance imaging (MRI), computed tomography (CT) or ultrasonography (US)]. Pathological findings, FDG PET scan during the next menstrual cycle and follow-up images (PET, CT and MRI) were reviewed. To establish the relation of FAOs to the menstrual cycle, we reviewed whole-body FDG PET acquired from 207 consecutive women and the pre-examination questionnaires, including data regarding the menstrual cycle. All spherical or discoid FAOs were attributed to normally developing ovarian follicles and corpora lutea on the basis of concurrent MRI, US or the follow-up PET scan. Three of the FAOs were proved pathologically to be either normal ovaries or a haemorrhagic corpus luteum. Fifteen FAOs spontaneously disappeared on the short-term follow-up PET scans. Of 207 women, 61 had active menstrual cycles. FAOs were found in 12 out of 61 premenopausal women (20%), appearing between the 10th and 25th days of the menstrual cycle. No FAOs were found in the women who did not have a menstrual cycle. Physiological ovarian FDG accumulation could be found around the time of ovulation and during the early luteal phase of the menstrual cycle in premenopausal woman. Since FAO is dependent on the menstrual cycle, it can be avoided by scheduling PET just after menstruation.
Tài liệu tham khảo
Engel H, Steinert H, Buck A, Berthold T, Rahel A, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441–6.
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409–15.
Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;26:308–14.
Pringle C, Dehdashti F. Metastatic malignant melanoma. On: Mallinckrodt Institute of Radiology website, http://gamma.wustl.edu/pt004te198.html, accessed December 9, 2004.
von Schulthess GK. Clinical PET and PET/CT imaging in body oncology. In: von Schulthess GK, editors. Clinical molecular anatomic imaging. Philadelphia, PA: Lippincott; 2003. p. 249.
Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging 1999;2(5):273–9.
Brown HK, Hazelton TR, Parsons AK. Magnetic resonance imaging of the normal female pelvis. In: Jaffe R, editor. Imaging infertility and reproductive endocrinology. Philadelphia, PA: Lippincott; 1994. p. 240–1.
Balsara G, Hernandez E. The ovary: normal, physiologic changes, endometriosis, and metastatic tumors. In: Hernandez E, Atkinson BF, editors. Clinical gynecologic pathology. Philadelphia, PA: Saunders; 1995. p. 404–9.
Bomsel-Helmreich O, Al-Mufti W. Ultrasonography of normal abnormal follicular development. In: Jaffe R, editors. Imaging infertility and reproductive endocrinology. Philadelphia, PA: Lippincott; 1994. p. 118–20.
Lunn SF, Fraser HM, Mason HD. Structure of the corpus luteum in the ovulatory polycystic ovary. Hum Reprod 2002;17:111–7.
Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004;45:266–71.
Rebar RW. The normal menstrual cycle. In: Keye WR, editors. Infertility: evaluation and treatment. Philadelphia, PA: Saunders; 1995. p. 85.